An integrated biomarker of <scp>PD‐L1</scp> expression and intraepithelial <scp>CD8</scp> <sup>+</sup> T cell infiltration was associated with the prognosis of lung cancer patients after intracranial resection of brain metastases-Reference-Cited by-同舟云学术

An integrated biomarker of PD‐L1 expression and intraepithelial CD8 ⁺ T cell infiltration was associated with the prognosis of lung cancer patients after intracranial resection of brain metastases

Published:2022-05-20 Issue:13 Volume:13 Page:1948-1960
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Li Lin‐Lin¹²^ORCID,Zhou De‐Xiang³,Lu Ming⁴,Zhou Dong³,Lin Xiao‐Feng³,Chen Yu²⁵,Yin Kai¹²,Feng Hui‐Bo²⁵,Guo Wei‐Bang²,Xie Zhi²,Yan Wen‐Qing²,Lv Zhi‐Yi²,Lu Dan‐Xia²,Zhang Shui‐Lian²,Zhang Xu‐Chao¹²⁵^ORCID

Affiliation:

1. The Second School of Clinical Medicine Southern Medical University Guangzhou China

2. Guangdong Lung Cancer Institute, Medical Research Center Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences Guangzhou China

3. Department of Neurosurgery, Guangdong Provincial People's Hospital Guangdong Academy of Medical Sciences Guangzhou China

4. Guangdong 999 Brain Hospital Guangzhou China

5. Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital Guangdong Academy of Medical Sciences Guangzhou China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14473

Reference41 articles.

1. Systematic Review of Brain Metastases in Patients With Non–Small-Cell Lung Cancer in the United States, European Union, and Japan

2. Brain metastases: epidemiology

3. First-Line Afatinib versus Chemotherapy in Patients with Non–Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain Metastases

4. Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial

5. Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distribution characteristics and prognosis of tumor-infiltrating lymphocytes in the brain metastases of small cell lung cancer: a retrospective cohort study;Translational Cancer Research;2024-05

2. Nanoparticles overcome adaptive immune resistance and enhance immunotherapy via targeting tumor microenvironment in lung cancer;Frontiers in Pharmacology;2023-03-24

3. FHL1 as a novel prognostic biomarker and correlation with immune infiltration levels in lung adenocarcinoma;Immunotherapy;2023-03